UNC Health Medication Formulary
Add Formweb to your mobile device
System Formulary Update
Bimatoprost (Durysta)
May 21, 2025
Situation: Bimatoprost intracameral implant (Durysta) was approved for removal fromthe UNC Health System Formulary at the System Pharmacy and Therapeutics Committee meeting.
Background: The following medication was reviewed: Bimatoprost intracameral implant
Assessment/Recommendation: System P&T voted to remove the following product to the UNC Health Medication Formulary: Bimatoprost intracameral implant (Durysta) 10 mg
Formulary/Epic Changes will Go-Live on Tuesday, July 8th